Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis
Xu Yan, Xin-Yi Liu, Dian Zhang, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2344-2357
Open Access | Times Cited: 91

Showing 26-50 of 91 citing articles:

Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota
Guigen Teng, Haohuan Li, Yun Liu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 31
Biosynthesis of diverse α,ω-diol-derived polyhydroxyalkanoates by engineered Halomonas bluephagenesis
Xu Yan, Xu Liu, Linping Yu, et al.
Metabolic Engineering (2022) Vol. 72, pp. 275-288
Closed Access | Times Cited: 26
Engineered bacteria as drug delivery vehicles: Principles and prospects
Yuxi Zhou, Yong Chol Han
Engineering Microbiology (2022) Vol. 2, Iss. 3, pp. 100034-100034
Closed Access | Times Cited: 26
Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease
Wanyue Fu, Lingling Xu, Z Chen, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 149-179
Closed Access | Times Cited: 19
The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review
Tao Zhang, Jindong Zhang, Liping Duan
Nutrients (2023) Vol. 15, Iss. 7, pp. 1566-1566
Open Access | Times Cited: 16
Elevated serum β-hydroxybutyrate, a circulating ketone metabolite, accelerates colorectal cancer proliferation and metastasis via ACAT1
Tianxiao Mao, Fujian Qin, Mengdi Zhang, et al.
Oncogene (2023) Vol. 42, Iss. 23, pp. 1889-1899
Closed Access | Times Cited: 16
Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for Escherichia coli Nissle 1917
Siyan Zhou, Linlin Zhao, Wenjie Zuo, et al.
Synthetic and Systems Biotechnology (2024) Vol. 9, Iss. 1, pp. 165-175
Open Access | Times Cited: 5
Review of the Potential of Probiotics in Disease Treatment: Mechanisms, Engineering, and Applications
Mingkang Liu, Jinjin Chen, Ida Putu Wiweka Dharmasiddhi, et al.
Processes (2024) Vol. 12, Iss. 2, pp. 316-316
Open Access | Times Cited: 5
Gut microbiota mediates the protective effects of β-hydroxybutyrate against cisplatin-induced acute kidney injury
Ruixue Tian, Xingru Wang, Shuqin Tang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116752-116752
Open Access | Times Cited: 4
Engineered extracellular vesicles for tissue repair and regeneration
Yan Zhang, Dan Wu, Zhou Chen, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 4
Poly-β-hydroxybutyrate alleviated diarrhea and colitis via Lactobacillus johnsonii biofilm-mediated maturation of sulfomucin
Ning Ma, Pingting Guo, Jingyu Chen, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 7, pp. 1569-1588
Closed Access | Times Cited: 21
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases
Jiao Meng, Shufan Liu, Xin Wu
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 3, pp. 300-314
Closed Access | Times Cited: 13
Reductase-Labile Peptidic Supramolecular Hydrogels Aided in Oral Delivery of Probiotics
Jiali Chen, Pai Zhang, Chengling Wu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 26, pp. 31214-31223
Closed Access | Times Cited: 13
Current status and challenges in the application of microbial PHA particles
Jiaxuan Liu, Ziqi Zhou, Hao‐Ru Li, et al.
Particuology (2023) Vol. 87, pp. 286-302
Closed Access | Times Cited: 12
An engineered Escherichia coli Nissle 1917 increase the production of indole lactic acid in the gut
Chrysoula Dimopoulou, Mareike Bongers, Mikael Pedersen, et al.
FEMS Microbiology Letters (2023) Vol. 370
Closed Access | Times Cited: 10
Genetically engineered bacteria: a new frontier in targeted drug delivery
Saba Fooladi, Navid Rabiee, Siavash Iravani
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 42, pp. 10072-10087
Closed Access | Times Cited: 10
The Potential of Probiotics in Disease Treatment: Mechanisms, Engineering, and Applications
Mingkang Liu, Jinjin Chen, Ida Putu Wiweka Dharmasiddhi, et al.
(2024)
Open Access | Times Cited: 3
Escherichia coli Nissle 1917 Protects against Sepsis-Induced Intestinal Damage by Regulating the SCFA/GPRs Signaling Pathway
Yajie Wang, Huan Deng, Lin Xiao, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1622-1622
Open Access | Times Cited: 3
Function and treatment strategies of β-hydroxybutyrate in aging
Yang Xiang, Qiquan Wang, Xinqiang Lan, et al.
Smart Materials in Medicine (2022) Vol. 4, pp. 160-172
Open Access | Times Cited: 17
A Polyhydroxyalkanoates-Based Carrier Platform of Bioactive Substances for Therapeutic Applications
Xu Zhang, Xin-Yi Liu, Hao Yang, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 9
Open Access | Times Cited: 15
Regulatory effect of lactulose on intestinal flora and serum metabolites in colitis mice: In vitro and in vivo evaluation
Junying Bai, Botao Wang, Xiang Tan, et al.
Food Chemistry X (2023) Vol. 19, pp. 100821-100821
Open Access | Times Cited: 8
Bioinspired and biomimetic strategies for inflammatory bowel disease therapy
Limei Zhang, Ye Peng, Huatai Zhu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 15, pp. 3614-3635
Closed Access | Times Cited: 2
Deciphering the Crucial Roles of the Quorum-Sensing Transcription Factor SdiA in NADPH Metabolism and (S)-Equol Production in Escherichia coli Nissle 1917
Zhe Wang, Yiqiang Dai, Fidelis Azi, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 259-259
Open Access | Times Cited: 2
Engineered microorganisms: A new direction in kidney stone prevention and treatment
Wenlong Wan, Weisong Wu, Yirixiatijiang Amier, et al.
Synthetic and Systems Biotechnology (2024) Vol. 9, Iss. 2, pp. 294-303
Open Access | Times Cited: 2
The role of gut microbiota associated metabolites in digestive disorders
Na Li, Cheng Zhao, Pingnan Zhang, et al.
Engineered Regeneration (2024) Vol. 5, Iss. 2, pp. 228-246
Open Access | Times Cited: 2

Scroll to top